Dr. Braconi is a Lord Kelvin Adam Smith Reader in the Institute of Cancer Sciences.  She possesses an honorary contract as Consultant Medical Oncologist at the Beatson West of Scotland Cancer Centre. Her research is focused on hepato-pancreaticobiliary tumors and aims at delineating novel treatment strategies for these cancers by integrating genomics, epigenomics, and patient-derived models for the identification of novel therapeutic targets and biomarkers.